|
02 Apr 2020 |
Evotec Expands its iPSC-Based Cell Therapy Platform EVOcells Through Licensing Agreement with panCELLa
|
|
02 Apr 2020 |
AC Immune Presents the Latest Preclinical Data on Novel Drug Targets for Neurodegenerative Diseases
|
|
01 Apr 2020 |
Neurimmune and Ethris Sign Collaboration Agreement to Rapidly Develop Inhaled mRNA-based Antibody Therapy for the Treatment of COVID-19
|
|
01 Apr 2020 |
Daiichi Sankyo Enters into Strategic Partnership with Ultragenyx for Use of Gene Therapy Manufacturing Technology
|
|
01 Apr 2020 |
REGENXBIO and Ultragenyx Announce New License Agreement for Use of NAV® Technology Platform for the Treatment of Rare Metabolic Disorder
|
|
01 Apr 2020 |
Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines
|
|
27 Mar 2020 |
CG Oncology Announces License and Commercialization Agreement with Kissei Pharmaceutical Co., Ltd. for CG0070 in Japan and Other Asian Countries
|
|
26 Mar 2020 |
ReCode Therapeutics Raises $80 Million in Oversubscribed Series A Financing
|
|
26 Mar 2020 |
Evox Therapeutics and Takeda sign multi-target rare disease collaboration
|
|
26 Mar 2020 |
Saniona enters into second collaboration agreement with Boehringer Ingelheim in schizophrenia
|
|
26 Mar 2020 |
Laekna Acquires Exclusive Global Rights to Clinical-Stage Cancer Asset
|
|
26 Mar 2020 |
Forge Enters Into Collaboration With Roche To Develop Novel Antibiotic To Treat Lung Infections
|
|
26 Mar 2020 |
Debiopharm Expands Its Radiopharmaceutical Footprint with an Exclusive In-Licensing Agreement of 3B Pharmaceutical's Targeted CAIX Radiotherapy
|
|
26 Mar 2020 |
Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China
|
|
25 Mar 2020 |
AstraZeneca to discover and develop siRNA therapeutics for Cardiovascular, Renal, Metabolic and Respiratory diseases in new collaboration
|
|
24 Mar 2020 |
CytomX Therapeutics and Astellas Announce Strategic Collaboration to Develop Probody® T-Cell Engaging Bispecific Therapies for Treatment of Cancer
|
|
24 Mar 2020 |
Pieris Pharmaceuticals Provides Update on Servier Collaboration
|
|
24 Mar 2020 |
Secarna Pharmaceuticals announces the acquisition of LNAplus based antisense drug candidates by Lipigon Pharmaceuticals
|
|
23 Mar 2020 |
Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders
|
|
23 Mar 2020 |
NeoImmuneTech Enters into Exclusive License Agreement with Ubix Therapeutics to Develop Drug Candidates Including T Cell Suppressor Blockade
|
|
23 Mar 2020 |
Bayer and Curadev sign research collaboration and license agreement to develop novel STING antagonists across indications
|
|
18 Mar 2020 |
Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies
|
|
18 Mar 2020 |
RIBOMIC Enters License Agreement with AJU Pharma for RBM-007 in Age-related Macular Degeneration
|
|
18 Mar 2020 |
HORAMA Signs Exclusive License Agreement with Leiden University Medical Center Targeting CRB1 Gene Mutations to Treat Inherited Retinal Dystrophies
|
|
17 Mar 2020 |
Eureka Therapeutics Completes $45 Million Series E Financing and Enters into Strategic Collaboration with Lyell Immunopharma
|
